EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reducing Peptidoglycan Crosslinking by Chemical Modulator Reverts β‐lactam Resistance in Methicillin‐Resistant Staphylococcus aureus

Ji-Hoon Kim, Yunmi Lee, Inseo Kim, JuOae Chang, Subin Hong, Na Kyung Lee, David Shum, Seongeun Baek, Wooseong Kim, Soojin Jang, Wonsik Lee iD

Advanced Science · 2024-07 · 11 (28)

DOI: 10.1002/advs.202400858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.05.2024. Verfasst von Ji-Hoon Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Peptidoglycan, beta-Lactam Resistance, Anti-Bacterial Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small molecule can be utilized to restore the effectiveness of existing major classes of antibiotics against antibiotic‐resistant bacteria. In this study, it is demonstrated that celastrol, a natural compound, can modify the bacterial cell wall and subsequently render bacteria more suceptible to β‐lactam antibiotics. It is shown that celastrol leads to incomplete cell wall crosslinking by modulating levels of c‐di‐AMP, a secondary messenger, in methicillin‐resistant Staphylococcus aureus (MRSA). This mechanism enables celastrol to act as a potentiator, effectively rendering MRSA susceptible to a range of penicillins and cephalosporins. Restoration of in vivo susceptibility of MRSA to methicillin is also demonstrated using a sepsis animal model by co‐administering methicillin along with celastrol at a much lower amount than that of methicillin. The results suggest a novel approach for developing potentiators for major classes of antibiotics by exploring molecules that re‐program metabolic pathways to reverse β‐lactam‐resistant strains to susceptible strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusPeptidoglycanbeta-Lactam ResistanceAnti-Bacterial AgentsAnimalsDisease Models, AnimalMicrobial Sensitivity TestsMicePentacyclic TriterpenesStaphylococcal InfectionsCell Wallbeta-LactamsTriterpenes

Stichwörter der Autor:innen

Staphylococcus aureuscelastrolc‐di‐AMPpeptidoglycanβ‐lactam resistance

Substanzen

PeptidoglycanAnti-Bacterial AgentscelastrolPentacyclic Triterpenesbeta-LactamsTriterpenes

Autor:innen und Institutionen

  • School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Antibacterial Resistance Laboratory, Institut Pasteur Korea, Seongnam, 13488, Republic of Korea.
  • Screening Discovery Platform, Institut Pasteur Korea, Seongnam, 13488, Republic of Korea.
  • College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.

ORCID-Profile: Wonsik Lee

Förderung

  • National Research Foundation of Korea
  • Korean government (MSIT)

Zitieren

APA

Kim, J. H., Lee, Y., Kim, I., Chang, J., Hong, S., Lee, N. K., Shum, D., Baek, S., Kim, W., Jang, S., & Lee, W. (2024). Reducing Peptidoglycan Crosslinking by Chemical Modulator Reverts β‐lactam Resistance in Methicillin‐Resistant Staphylococcus aureus. Advanced Science, 11(28). https://doi.org/10.1002/advs.202400858

Vancouver

Kim JH, Lee Y, Kim I, Chang J, Hong S, Lee NK, et al. Reducing Peptidoglycan Crosslinking by Chemical Modulator Reverts β‐lactam Resistance in Methicillin‐Resistant Staphylococcus aureus. Advanced Science. 2024;11(28). doi:10.1002/advs.202400858

BibTeX
@article{Kim2024,
  author = {Kim, Ji-Hoon and Lee, Yunmi and Kim, Inseo and Chang, JuOae and Hong, Subin and Lee, Na Kyung and Shum, David and Baek, Seongeun and Kim, Wooseong and Jang, Soojin and Lee, Wonsik},
  title = {Reducing Peptidoglycan Crosslinking by Chemical Modulator Reverts β‐lactam Resistance in Methicillin‐Resistant Staphylococcus aureus},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {28},
  doi = {10.1002/advs.202400858}
}
Kostenlos starten →